Skip to main navigation

Investors
Contact

About
Investors
Investors
Shareholder Tools
Newsroom
Contact

Investor Information

AddThis Sharing Buttons

Share to LinkedIn Share to Facebook Share to Twitter

News Releases

Keyword Search

Year

August 27, 2020

Zomedica Shareholder Letter

August 27, 2020

Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting

August 10, 2020

Zomedica Announces Second Quarter 2020 Financial Results

August 7, 2020

Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability

August 3, 2020

Zomedica Announces Management Change

July 21, 2020

Successful Remote Installation of TRUFORMA™

July 7, 2020

Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering

July 1, 2020

Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering

July 1, 2020

Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering

June 16, 2020

Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Investors

Investor Overview
News Releases
Events & Presentations
Stock Information
Financial Information
Corporate Governance
Investor FAQs
Email Alerts
Contact IR

Shareholder Tools

Email Alerts
RSS Feeds
Print Page
Share This

X

LinkedIn
Facebook
Twitter

OUR VISION & MISSION

Advancing the health, effectiveness, and financial well-being of the companion animal veterinarian by delivering economically and professionally beneficial products and services.

Zomedica on LinkedIn
Zomedica on Facebook
Zomedica on Youtube
Zomedica on Twitter

© 2021 Zomedica Corp. and Zomedica Inc. All Rights Reserved.

Privacy Notice
Terms of Use
Forward Looking Statements